📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004120

PubMed Identifier: 36260627

Publication URI: http://europepmc.org/abstract/MED/36260627

Type: Journal Article/Review

Volume: 19

Parent Publication: PLoS medicine

Issue: 10

ISSN: 1549-1277